[go: up one dir, main page]

Kerbel et al., 1977 - Google Patents

Analysis of established human carcinoma cell lines for lymphoreticular‐associated membrane receptors

Kerbel et al., 1977

Document ID
16918666505590367383
Author
Kerbel R
Pross H
Leibovitz A
Publication year
Publication venue
International Journal of Cancer

External Links

Snippet

Thirty‐one different long‐term established human carcinoma culture cell lines were examined for the presence or absence of receptors for the Fc portion of immunoglobulin G (IgG)(“Fc receptors”), the third component of complement (C3 receptors), sheep erythrocytes …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Similar Documents

Publication Publication Date Title
Gangopadhyay et al. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells
Schlossman et al. Distribution of Ia-like molecules on the surface of normal and leukemic human cells.
Engelhardt et al. Immunofluorescent study of alpha‐foetoprotein (αfp) in liver and liver tumours. I. Technique of αfp localization in tissue sections
Giacomini et al. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma
Kerbel et al. Analysis of established human carcinoma cell lines for lymphoreticular‐associated membrane receptors
Kaszubowski et al. T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients
Macanovic et al. Allergic response to glomerular basement membrane in patients with glomerulonephritis
Stein The immunologic and immunochemical basis for the Kiel classification
Yata et al. Human thymus-lymphoid tissue antigen and its presence in leukaemia and lymphoma
Murgita et al. Effects of human alpha-foetoprotein on human B and T lymphocyte proliferation in vitro
Lozzio et al. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562
Spiegelberg et al. Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes
Stück et al. Antigenic conversion of established leukaemias by an unrelated leukaemogenic virus
Sofen et al. Anti-squamous tumor antibodies in patients with squamous cell carcinoma
Palosuo et al. Gold nephropathy: serologic data suggesting an immune complex disease
Oh et al. Soluble HL‐A antigens in serum. I. Isolation and Purification
Jacobs et al. Inhibition of lymphocyte blastogenesis by sera from cows with lymphoma
Horny et al. Immunoreactivity of normal and neoplastic human tissue mast cells
Evarts et al. Modulation of asialoglycoprotein receptor levels in rat liver by phenobarbital treatment
Heaney-Kieras et al. Identification and purification of a M, 75,000 cell surface human melanoma-associated antigen
Gupta et al. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography
Gorsky et al. Isolation from patients with breast cancer of antibodies specific for antigens associated with breast cancer and other malignant diseases.
Bodenheimer Jr et al. Characterization of a new monoclonal antibody to rat macrophages and Kupffer cells
Abelev Alphafetoprotein: the genesis
Hirai et al. Purification of specific antibody to α-foetoprotein and its immunological effect on cancer cells